In the same quarter of the previous year, the diagnostic chain had posted Rs. 29 crores was reported as net profit.
Income from operations rose 13.1% YoY to Rs. 313.4 crores.
Earnings before interest, tax, depreciation and amortization (EBITDA) before CSR and ESOP rose 20.2% YoY in Q1 to Rs. 80.5 crores. EBITDA margin was 25% in Q1FY25.
Growth in patient volume and test volume for the quarter was 7% and 10%, respectively. Revenue per patient increased by 6%.
“Our TrueHealth (wellness and bundling) segment grew by 28% this quarter, which helped us move customers further up the value chain, resulting in increased revenue per patient,” said Amira Shah, executive chairperson and whole-time director. , Metropolis Healthcare.
“We are confident that network expansion, growing people and changing test mix will continue to help us achieve our desired growth,” Shah added.
Metropolitan has a network of 204 labs, 4216 collection centers and over 10,000 touch points.
(You can now subscribe to our ETMarkets WhatsApp channel)